Venture Visionary Partners’s Boston Scientific BSX Stock Holding History

Venture Visionary Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$488K	Sell	11,438 -5,439	-32%	-$295K	0.01%	478
2026 Q1	$1.06M	Sell	16,877 -3,987	-19%	-$319K	0.04%	310
2025 Q4	$1.99M	Sell	20,864 -561	-3%	-$55K	0.06%	223
2025 Q3	$2.09M	Buy	21,425 +8,874	+71%	+$919K	0.07%	201
2025 Q2	$1.35M	Buy	12,551 +6,575	+110%	+$665K	0.05%	250
2025 Q1	$603K	Buy	5,976 +1,272	+27%	+$128K	0.03%	351
2024 Q4	$420K	Sell	4,704 -808	-15%	-$71.1K	0.02%	399
2024 Q3	$462K	Sell	5,512 -342	-6%	-$27K	0.02%	390
2024 Q2	$451K	Buy	5,854 +808	+16%	+$59.1K	0.02%	393
2024 Q1	$346K	Buy	5,046 +104	+2%	+$6.69K	0.02%	436
2023 Q4	$286K	Hold	4,942	–	–	0.02%	440
2023 Q3	$261K	Hold	4,942	–	–	0.02%	438
2023 Q2	$267K	Hold	4,942	–	–	0.02%	436
2023 Q1	$247K	Hold	4,942	–	–	0.02%	436
2022 Q4	$229K	Buy	+4,942	New	+$214K	0.02%	428
2022 Q3	–	Sell	-4,941	Closed	-$184K	–	605
2022 Q2	$184K	Hold	4,941	–	–	0.01%	462
2022 Q1	$218K	Hold	4,941	–	–	0.01%	463
2021 Q4	$209K	Hold	4,941	–	–	0.01%	483
2021 Q3	$214K	Sell	4,941 -27	-0.5%	-$1.2K	0.02%	474
2021 Q2	$212K	Buy	+4,968	New	+$209K	0.02%	463

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Venture Visionary Partners's BSX Position: Q2 2026 in Review

Venture Visionary Partners reduced its Boston Scientific (BSX) stake by 32% in Q2 2026, selling an estimated $295K and leaving 11,438 shares worth $488K. The position accounts for 0.01% of the portfolio, ranked #478.

Venture Visionary Partners first reported a position in BSX in Q2 2021 and has held it in 20 quarters since. The position peaked at $2.09M in Q3 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Venture Visionary Partners held 11,438 shares of Boston Scientific worth $488K as of Q2 2026.
Venture Visionary Partners sold 5,439 Boston Scientific shares in Q2 2026, an estimated $295K.
Boston Scientific made up 0.01% of Venture Visionary Partners's portfolio in Q2 2026, its #478 holding.
Venture Visionary Partners first reported a position in Boston Scientific in Q2 2021 and has held it in 20 quarters since.
Venture Visionary Partners's Boston Scientific position peaked at $2.09M in Q3 2025.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Venture Visionary Partners's 13F filing for Q2 2026, filed 27 Jul 2026.